Antigen News and Research

RSS
Sustainable material-based biosensors for SARS-CoV-2 detection

Sustainable material-based biosensors for SARS-CoV-2 detection

15 Mar 2022
SARS-CoV-2 in diabetes pathogenesis

SARS-CoV-2 in diabetes pathogenesis

15 Mar 2022
Rise in metastatic prostate cancer coincides with recommendations against routine screenings

Rise in metastatic prostate cancer coincides with recommendations against routine screenings

14 Mar 2022
Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

14 Mar 2022
Role of carboxypeptidase U in severe COVID-19

Role of carboxypeptidase U in severe COVID-19

14 Mar 2022
Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

11 Mar 2022
Sporadic Legionnaires’ disease in commercial truck drivers could be attributed to vehicle windshield wiper fluid

Sporadic Legionnaires’ disease in commercial truck drivers could be attributed to vehicle windshield wiper fluid

10 Mar 2022
Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

10 Mar 2022
Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

10 Mar 2022
Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

10 Mar 2022
The trajectory of B-cell immunity six months after mRNA vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

10 Mar 2022
Novel radioligand therapy shown to increase survival of metastatic prostate cancer patients

Novel radioligand therapy shown to increase survival of metastatic prostate cancer patients

9 Mar 2022
Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

9 Mar 2022
Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

9 Mar 2022
A predictive model for COVID-19 outcomes

A predictive model for COVID-19 outcomes

9 Mar 2022
Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

9 Mar 2022
Whole-genome sequencing for determination of factors associated with critical COVID-19

Whole-genome sequencing for determination of factors associated with critical COVID-19

8 Mar 2022
Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

8 Mar 2022
Study identifies new immune checkpoint that may be exploited for cancer treatment

Study identifies new immune checkpoint that may be exploited for cancer treatment

8 Mar 2022
Omicron-based vaccine candidate generated to assess whether immunogenicity could be further improved

Omicron-based vaccine candidate generated to assess whether immunogenicity could be further improved

8 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback